ClinicalTrials.gg
Active, not recruitingNCT06879912Updated Sep 4, 2026

A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot

An observational study in Hernia, Inguinal, Hernia, Ventral and Colorectal, sponsored by Intuitive Surgical. Active, not recruiting at 6 sites in United States. Open to participants aged 22 Years and older. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by Intuitive Surgical · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
200
Ages
22 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 77 studies in Hernia, Inguinal with a site in United States — 9 open to participants now, 20 under way, none of them phase 3. Hernia, Inguinal · United States.

Planned enrollment
5th of 17
200 · median 116
Started
2025
with 2 others
Observational
17 of 77
1 open now
Primary completion
2026-08
later than 6 of 19 live
Registered
70th of 77
by date
Lead sponsor
6 of 77
Intuitive Surgical

Among the 77 studies in Hernia, Inguinal with a site in United States, this one is the 5th largest by planned enrollment of the 17 observational ones that give a count, is one of 3 that started in 2025, is one of 17 observational ones, reaches primary completion later than 6 of the 19 other live ones, and was the 70th registered.

Hernia, Inguinal

544 studies on the registry are indexed under Hernia, Inguinal; 92 are open to participants now.

Browse Hernia, Inguinal studies →

Open to participants now

9 of the 77 studies in Hernia, Inguinal with a site in United States are open now. Recruiting first, the newest first:

4 more — sign in →

All 9 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 56 Hernia, Inguinal studies recruiting now, 30 (54%) set no upper age limit and 17 (30%) stop at 75 or younger; 16 take children under 18; 9 take healthy volunteers.

This study: 22 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 77 studies in Hernia, Inguinal with a site in United States, or all of them as a file.
02

Study summary

The goal of this observational study is to understand the utility of force feedback instruments in surgeries that are done using the da Vinci 5 robot.

03

Conditions studied

  • Hernia, Inguinal
  • Hernia, Ventral
  • Colorectal
  • Thoracic
  • Gynecologic
  • Partial Nephrectomy
04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subjects who will undergo the study specified procedure as primary procedure with da Vinci 5 robot and who meet all eligibility criteria will be considered for enrollment.

Eligibility criteria

Pre-Operative Inclusion Criteria:

  1. Age 22 years or older
  2. ASA ≤ 3
  3. The clinical decision has been made to perform multi-port robotic assisted surgery with da Vinci 5 with Force Feedback instruments for the study specified procedure as primary procedure prior to enrollment in the study
  4. Subject or a legally authorized representative is able to provide written using the study informed consent form prior to the study
  5. Subject is willing and able to comply with the study protocol requirements including follow up schedule

Pre-operative Exclusion Criteria:

  • Subject receiving an emergent procedure
  • Subject planned to undergo major concomitant surgery for the treatment of a different medical condition than was originally planned
  • Subject with previous ipsilateral surgery (open, endoscopic or robotic) with the same surgical indication
  • Subject with past or ongoing medical conditions (for example: inflammatory bowel disease) which, in the judgment of the Investigator, puts them at high risk for surgery and not appropriate for the study
  • Subject is pregnant or suspected to be pregnant or breastfeeding
  • Subject has any other condition or personal circumstance that, in the judgment of the Investigator, might interfere with the collection of complete quality data
  • Subject is currently participating in or has participated in a study of an agent or a significant risk investigational device study within the past 6 months
  • Subject belongs to a vulnerable population.
  • Subject is for anesthesia or surgery.

Intra-operative Exclusion Criteria

  • Subject with hemodynamic or respiratory instability, which precludes the Investigator from performing the RAS.
  • Subject in whom inadequate visualization makes a minimally invasive approach not feasible, as determined from the investigator assessment prior to docking the robot.
  • Subject with adhesions, scarring and disease status in the body which in the opinion of the investigator limits the ability to perform the minimally invasive procedure.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Investigational drug or device

A drug or device being studied in a clinical trial.

It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. To assess the force imparted on the tissue by force feedback instruments.

    Time frame: Intra-operative

Secondary outcomes

  1. To evaluate the utility of force feedback instruments during specific procedural steps or tasks.

    Time frame: Post-operative prior to discharge

07

Study locations

6 sites
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2025 to primary completion in Aug 2026, 14 months.

Of 57 observational studies under Hernia, Inguinal, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 68. This study's 14 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 11, 2025
First posted
Mar 17, 2025
StartActual
May 24, 2025
Primary completionActual
Aug 19, 2026
CompletionEst.
Jan 2027
Last update
Sep 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06879912
Lead sponsor
Intuitive Surgical
Responsible party
Sponsor
First posted
Mar 17, 2025
Start date
May 24, 2025
Primary completion
Aug 19, 2026
Completion
Jan 2027 (estimated)
Last update
Sep 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion